Rui Lyu

7PUBLICATIONS
40CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedMedical mycologyMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 07, 2025
Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study.

Wenjie Xiong, Yuting Yan, Tingyu Wang

|Oct 17, 2024
γδ and αβ T-cell large granular lymphocytic leukaemia have similar characteristics and outcomes.

Rui Cui, Ying Yu, Yuxi Li

|Oct 07, 2024
Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström Macroglobulinemia.

Yuting Yan, Ying Yu, Wenjie Xiong

|Jun 20, 2024
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing.

Jian Cui, Xiaoyun Li, Shuhui Deng

|May 10, 2022
Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM.

Jun Wang, Yuting Yan, Wenjie Xiong

|Jul 30, 2021
Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma.

Rui Lyu, Tingyu Wang, Yi Wang

Pageof 2